Jun 03, 2020 / 02:30PM GMT
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity Analyst
Well, good morning, everyone, and thank you for joining us as we continue an exciting day here at the 2020 Jefferies Global Healthcare Conference.
I don't know if there's anyone or any company more in the spotlight these days with the exciting developments going on at Moderna. So I'm very happy to have with us here the CEO of Moderna, Stéphane Bancel.
Stéphane, thanks for joining us at such a crucial time, both in Moderna's history, both with the exciting developments in -- with your pipeline, but certainly, of course, with all the things going on in the world.
Questions and Answers:
Michael Jonathan Yee - Jefferies LLC, Research Division - Equity AnalystI guess I just wanted to start off with the first question or first topic, I'd say. You obviously have quickly evolved the platform and have built a huge pipeline. Maybe just spend a moment talking first since you had a Science R&D Day yesterday, before we jump into the nitty gritty of some of your programs,
Trustpilot
